Supriya Lifescience IPO GMP, Grey Market Premium & Kostak Rates Today

Supriya Lifescience IPO GMP, Grey Market Premium & Kostak Rates Today:- Here we provided Supriya Lifescience IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Supriya Lifescience IPO GMP started and looking strong.

Active pharmaceuticals ingredients manufacturer Supriya Lifescience has decided to launch its IPO on December 16, 2021. The company plans to raise up to Rs 700 crore through its public issue that comprises fresh issuance of shares worth Rs 200 crore and an offer for sale of Rs 500 crore by promoter Satish Waman Wagh. The company has niche product offerings of 38 active pharmaceuticals ingredients (APIs) focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic, as of October 2021. Data Patterns IPO

 

Supriya Lifescience IPO GMP, Grey Market Premium & Kostak Rates Today

 

What is Supriya Lifescience IPO GMP Today?

Supriya Lifescience IPO GMP aka grey market premium is Rs 130.

 

What is Supriya Lifescience IPO Kostak Rates Today?

Supriya Lifescience IPO kostak rate is Rs-.

 

What is Supriya Lifescience IPO Subject to Sauda Price Today?

Supriya Lifescience IPO subject to sauda rates is Rs 6000.

 

Supriya Lifescience IPO Expected Returns?

Supriya Lifescience expected return is 40%.

 

Supriya Lifescience IPO GMP Live Rates day by day with Kotak rates.

Supriya Lifescience IPO GMP Or Grey Market Premium Available Here.

Date GMP
Kostak Subject to
21 December Rs 130 Rs- Rs 6000
20 December Rs 180 Rs- Rs 6000
19 December Rs 180 Rs- Rs 6000
18 December Rs 280 Rs- Rs 6000
17 December Rs 280 Rs- Rs-
16 December Rs 250 Rs- Rs-
15 December Rs 250 Rs- Rs-
14 December Rs 250 Rs- Rs-
13 December Rs 400 Rs- Rs-
12 December Rs- Rs- Rs-

 

Supriya Lifescience IPO Date & Price Band

 IPO Open:  16 December 2021
 IPO Close:  20 December 2021
 IPO Size:  Rs 700 crore
 Fresh Issue:  Rs 200 crore
 Offer for Sale:  Rs 500 crore
 Face Value:  Rs 2 Per Equity Share
 Price Band:  Rs- to Rs- Per Share
 Listing on:  BSE & NSE
 Retail Quota:  10%
 QIB Quota:  75%
 NII Quota:  15%
 DRHP Draft Prospectus:  Click Here
 RHP Draft Prospectus:  Click Here

 

Supriya Lifescience IPO Market Lot

 Minimum Lot Size: Minimum- Shares for 1 lot
 Minimum Amount: Rs- lakh for 1 lot
 Maximum Lot Size: Maximum- Shares Shares for 13 lot
 Maximum Amount: Rs- for 13 lot

 

Supriya Lifescience IPO Reservation :

Category Reservation Shares Amount
QIB : 75% N/A N/A
NII : 15% N/A N/A
RII : 10% N/A N/A
EMP : N/A% N/A N/A
Total : 100 % N/A N/A

 

Supriya Lifescience IPO Dates, Allotment & Listing :

Supriya Lifescience IPO Date is 16 December 2021. The allotment date is 23 December 2021 and the IPO may list on 28 December 2021.

Open Date :   16 December 2021
Close Date :   20 December 2021
Allotment Date :   23 December 2021
Refund Date :   24 December 2021
Share Credit Date :   27 December 2021
Listing Date :   28 December 2021

 

Supriya Lifescience IPO Form

There are two ways to apply in Supriya Lifescience IPO. You can apply for Supriya Lifescience IPO through ASBA available in your bank account. You have to go to your online bank login and select Supriya Lifescience IPO in the Invest section and apply through your bank account. Another option is you can apply for Supriya Lifescience IPO through IPO form download through NSE and BSE. See the Supriya Lifescience IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.

 

Supriya Lifescience Financial Report:

Year Revenue Expense  PAT
2021 Rs 396.2 Crores Rs 218 Crores Rs 123.8 Crores
2020 Rs 322.7 Crores Rs 213.2 Crores Rs 73.4 Crores
2019 Rs 285.8 Crores Rs 213.1 Crores Rs 39.4 Crores

 

Promoters

  • Satish Waman Wagh

 

Supriya Lifescience IPO Registrar

Link Intime India Private Limited
C-101, 247 Park, 1st Floor,
L.B.S. Marg, Vikhroli West
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: [email protected]
Website: www.linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058

 

Supriya Lifescience IPO Lead Managers

  • ICICI Securities Limited
  • Axis Capital Limited

 

Company Address

Supriya Lifescience Limited
207/208, Udyog Bhavan, Sonawala Road,
Goregaon–East, Mumbai – 400063,
Maharashtra, India
Tel: +91-22-40332727
Contact Person: Shweta Shivdhari Singh
Company Secretary and Compliance Officer
Tel: +91-22-40332727
Website: www.supriyalifescience.com
Corporate Identity Number: U51900MH2008PLC180452OUR

 

Supriya Lifescience Board of Directors

 

Name Designation
Satish Waman Wagh Chairman and Managing Director
Smita Satish Wagh Whole-time Director
Saloni Satish Wagh Whole-time Director
Shivani Satish Wagh Whole-time Director
Balasahab Gulabrao Sawant Whole-time Director
Kedar Shankar Karmarkar Independent Director
Bhairav Manojbhai Chokshi Independent Director
Dileep Kumar Jain Independent Director
Dinesh Navnitlal Modi Independent Director
Neelam Yashpal Arora Independent Director

 

About Supriya Lifescience

We are one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, we have niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. We have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between Fiscal 2017 and 2021. We were among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms (Source: CRISIL Report).

Our customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom we have a business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom we have a business relationship for over four years. Our products are registered with various international regulatory authorities such as USFDA, EDQM, NMPA (previously known as SFDA), KFDA, PMDA, TGA and Taiwan FDA. As of October 31, 2021, we have filed 14 active DMFs with USFDA and eight active CEPs with EDQM, for our API products in therapeutic areas such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. For the Fiscals 2019, 2020, 2021 and for the six month period ended September 30, 2021, our export sales accounted for 70.96%, 71.85%77.47% and 73.57%, respectively of our revenue from operations. Similarly, for the Fiscals 2019, 2020,2021 and for the six month period ended September 30, 2021, our domestic sales accounted for 29.04%, 28.15%,22.53% and 26.43%, respectively, of our revenue from operations.

 

Supriya Lifescience IPO GMP aka Grey Market Premium FAQs:

 

What is Supriya Lifescience IPO GMP Today?
Supriya Lifescience IPO GMP is Rs- as of today.

 

What is Supriya Lifescience IPO Kostak Rate Today?
Supriya Lifescience IPO Kostak Rate is Rs- as of today.

 

What is Supriya Lifescience IPO Subject to Sauda Today?
Supriya Lifescience IPO Subject to Sauda is Rs- as of today.

 

What is Supriya Lifescience IPO Expected Returns?
Supriya Lifescience IPO Expected Returns is -%.

Leave a Reply

Your email address will not be published.